Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YM060 (Irribow) Phase II in Female D-IBS
NCT01274000Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ramosetron in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Astellas Pharma. Started Nov 2010; status: completed.
02
Drugs
ramosetron
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT01274000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01274000.